78.38
+3.13%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About RadNet
From its filings with the US Securities and Exchange Commission
RadNet is based in Los Angeles, California and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker RDNT. The SEC classifies its business as medical laboratories. In the fiscal year to 31 December 2025, it reported revenue of $2.04bn and a net loss of $18.7m. At that date it held total assets of $3.76bn and shareholders' equity of $1.09bn.
We are a leading national provider of diagnostic imaging services in the United States based on number of locations and annual imaging revenue. We have been in business since 1985. Our principal business segment is the provision of diagnostic imaging services. As of December 31, 2025, we operated, directly or indirectly through hospital and health system joint ventures, 418 imaging centers located in Arizona, California, Delaware, Florida, Maryland, Virginia, New Jersey, Texas and New York.
Our Imaging Centers segment provides physicians with capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, often reducing the cost and amount of care for patients. Our services include magnetic resonance imaging ("MRI"), computed tomography ("CT"), positron emission tomography ("PET"), nuclear medicine, mammography, ultrasound, diagnostic radiology ("X-ray"), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services, a key point of differentiation from our competitors. Our multi-modality strategy diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures. Integral to the imaging center business is our Digital Health operating segment, which sells computerized systems that distribute, display, store and retrieve digital images.
Quoted from its 10-K, filed 2 Mar 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 26 Feb 1991
- Employees
- 8,844
- Website
- radnet.com ↗
- Head office
- 1510 COTNER AVE, LOS ANGELES, CA, 90025
- Incorporated in
- DE
- Classification
- Services-Medical Laboratories
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Dr. Howard BergerChairman of the Board, President, Chief Executive Officer, since 1987$9.1m
- Mr. Mark StolperChief Financial Officer, Executive Vice President$1.9m
- Mr. Stephen ForthuberPresident and Chief Operating Officer- Eastern Operations$2.2m
- Mr. Norman HamesPresident and Chief Operating Officer - Western Operations, since 2019$2.1m
- Mr. Cornelis WesdorpPresident and Chief Executive Officer - Digital Health$4.3m
- Mr. Mital PatelExecutive Vice President - Financial Planning and Analysis, Chief Administrative Officer$1.9m
- Mr. Ranjan JayanathanExecutive Vice President, Chief Information Officer
- Mr. David KatzExecutive Vice President, Chief Legal Officer, Corporate Secretary
- Mr. Michael MurdockExecutive Vice President - Mergers and Acquisitions
- Mr. A. Gregory SorensenChief Science Officer, Director, since 2023$1.3m
- Mr. David SwartzLead Independent Director$297,994
- Ms. Laura JacobsIndependent Director$262,994
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 44
- Environment
- 6
- Social
- 63
- Governance
- 64
- Women in the workforce
- 81%
- Carbon reduction policy
- No
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- RadNet Inc has several strengths that contribute to its success:
Weaknesses
- Despite its strengths, RadNet Inc faces certain weaknesses:
Opportunities
- RadNet Inc can leverage the following opportunities in the market:
Threats
- There are several threats that RadNet Inc needs to address:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.